1. Hematologic Safety Profile of Linezolid in the Early Periengraftment Period after Allogeneic Stem Cell Transplantation 
Nina Cohen, Coralia N. Mihu, Susan K. Seo, Dick Chung, Joanne Chou, Glenn Heller, Genovefa A. Papanicolaou 
Biology of Blood and Marrow Transplantation 
Volume 15, Issue 10, Pages (October 2009)
DOI: /j.bbmt
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence for ANC 500 by treatment group. The solid line represents linezolid; the dashed line, vancomycin.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Cumulative incidence for PLT 20 by treatment group. The solid line represents linezolid; the dashed line, vancomycin.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2009 American Society for Blood and Marrow Transplantation Terms and Conditions